The effects of a long-duration intravenous infusion of detomidine, with and without vatinoxan, on equine energy metabolism and urine composition.

The research studied the impacts of a long term injection of detomidine, with and without vatinoxan, on horse energy metabolism and urine make-up. The report demonstrates that vatinoxan can ease the effects caused by detomidine such as low-insulin levels, high glucose levels, and excessive urination, potentially aiding in the sedation of horses.

Objective and Methodology

• The goal of the study was to investigate the effects of a four hour detomidine and vatinoxan constant rate infusion (CRI) on energy metabolism and urine composition in horses.
• This was a randomized, blinded, crossover study carried out on eight Finnish horses.
• The horses were given an intravenous (IV) detomidine loading dose followed by a 240 minutes CRI (referred to as DET), and the same detomidine regimen was combined with an IV vatinoxan loading dose and CRI (known as DET+VAT).
• During and after CRI, blood samples were taken to assess glucose, insulin, non-esterified fatty acid (sNEFA), and β-hydroxybutyrate (sBHB) levels. At the end of CRI, urine samples were collected for glucose and sodium concentration examinations.

Key Findings

• When using DET, blood glucose concentrations were significantly higher than those using DET+VAT.
• Insulin concentration was considerably lower with DET than with DET+VAT, reaching its highest level at the end of the follow-up period.
• Usage of DET+VAT resulted in significantly higher levels of sBHB and sNEFA compared to DET alone.
• Daily urination was more frequent during the usage of DET compared to DET+VAT.
• Significantly more glucose and sodium were found in the urine following the DET infusion compared to the DET+VAT infusion.

Conclusions

• The study results indicated that the addition of vatinoxan helped alleviate the hypoinsulinemia (deficient insulin levels in the blood) and hyperglycemia (excess blood sugar levels) caused by detomidine.
• Moreover, combining vatinoxan with detomidine also reduced the frequency of urination, the presence of glucose in urine (glucosuria), and sodium excretions during and after a 4-hour CRI.
• This suggests that vatinoxan may be beneficial in conjunction with standing sedation methods involving alpha2-adrenoceptor agonists, like detomidine.